AngioDynamics
ANGO
173 hedge funds and large institutions have $692M invested in AngioDynamics in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 54 reducing their positions, and 11 closing their positions.
40,300% more call options, than puts
Call options by funds: $404K | Put options by funds: $1K
55% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 11
37% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 54
4% more funds holding
Funds holding: 167 → 173 (+6)
0.61% more ownership
Funds ownership: 99.72% → 100.33% (+0.61%)
5% less capital invested
Capital invested by funds: $731M → $692M (-$39.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$5.1M |
| 2 |
Goldman Sachs
New York
|
+$3.14M |
| 3 |
Renaissance Technologies
New York
|
+$2.44M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$2.24M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.75M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.34M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$2.13M |
| 4 |
Squarepoint
New York
|
-$1.69M |
| 5 |
Axa
Paris,
France
|
-$1.57M |
ANGO Hedge Fund Activity: Q3 2019 in Review
173 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2019, worth a combined $692M — down 5.4% from $731M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ANGO positions and 11 closed out — a net gain of 6 holders — while 74 added to existing stakes and 54 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $5.1M. The largest seller was Millennium Management, cutting an estimated $5.75M.
- 173 institutional investors held AngioDynamics (ANGO) as of Q3 2019, up from 167 in Q2 2019.
- Funds reported $692M of AngioDynamics stock for Q3 2019, down 5.4% quarter-over-quarter.
- 17 funds opened new AngioDynamics positions in Q3 2019 and 11 closed out, a net change of +6 holders.
- The largest AngioDynamics buyer in Q3 2019 was Victory Capital Management, an estimated $5.1M added.
- The largest AngioDynamics seller in Q3 2019 was Millennium Management, an estimated $5.75M sold.
Based on aggregated 13F filings for Q3 2019.